These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31436592)

  • 1. Practical points for applying herpes zoster vaccine recommendations.
    Brogie JD; Rumph JH; Chaplin MD; Drake N; Hodge BK; Owens RE
    Nurse Pract; 2019 Sep; 44(9):43-47. PubMed ID: 31436592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.
    Sly JR; Harris AL
    Nurs Womens Health; 2018 Oct; 22(5):417-422. PubMed ID: 30145235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shingrix for Herpes Zoster: A Review.
    Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Zoster Vaccine (Shingrix) for the Prevention of Shingles.
    Deshpande L
    Am Fam Physician; 2018 Oct; 98(8):539-540. PubMed ID: 30277735
    [No Abstract]   [Full Text] [Related]  

  • 5. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
    Dooling KL; Guo A; Patel M; Lee GM; Moore K; Belongia EA; Harpaz R
    MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(3):103-108. PubMed ID: 29370152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on recommendations for use of herpes zoster vaccine.
    Hales CM; Harpaz R; Ortega-Sanchez I; Bialek SR;
    MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(33):729-31. PubMed ID: 25144544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
    James SF; Chahine EB; Sucher AJ; Hanna C
    Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster subunit vaccine for the prevention of herpes zoster.
    Symoniak MR; Farrokh P; Gandhi MA; Slish JC
    Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
    Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
    Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shingrix--an adjuvanted, recombinant herpes zoster vaccine.
    Med Lett Drugs Ther; 2017 Dec; 59(1535):195-196. PubMed ID: 29186082
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent Updates to the Advisory Committee On Immunization Practices Recommendations for Pneumococcal and Herpes Zoster Vaccination.
    Brotherton AL; Shah R
    R I Med J (2013); 2020 Aug; 103(6):34-37. PubMed ID: 32752563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.
    Oxman MN; Gershon AA; Poland GA
    Vaccine; 2011 May; 29(20):3625-7. PubMed ID: 21524565
    [No Abstract]   [Full Text] [Related]  

  • 13. What are the new vaccination recommendations for herpes zoster?
    Mospan CM; Colvin N
    JAAPA; 2018 Oct; 31(10):14-15. PubMed ID: 30252758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
    Keating GM
    BioDrugs; 2016 Jun; 30(3):243-54. PubMed ID: 27189459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shingles vaccine: which recommendations in 2014?].
    Vionnet J; Hart K; Spertini F
    Rev Med Suisse; 2014 Apr; 10(426):869-72, 874-5. PubMed ID: 24834646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella zoster virus redux.
    Gelb LD
    Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
    Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
    Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shingles vaccine.
    Willison CB; Morrison LK; Mendoza N; Tyring SK
    Expert Opin Biol Ther; 2010 Apr; 10(4):631-8. PubMed ID: 20113211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes Zoster and Vaccination Strategies in Inflammatory Bowel Diseases: A Practical Guide.
    Guillo L; Rabaud C; Choy EH; D'Amico F; Danese S; Ng SC; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):481-490. PubMed ID: 33080353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.